Scientific Program – GynecologySaturday, November 23, 2024 |
 |
| 08:30-09:00 | GOOD MORNING LISBON PLENARY LECTURE | HALL A |
| 09:00-10:30 | MENOPAUSE – WHAT’S NEW | HALL C |
| Capsule | ||
| Chairpersons | Santiago Palacios, Spain | |
| 09:00-09:45
09:00-09:15 |
Debate: NK receptor antagonists should be considered as a first line menopause treatment option in all women not contraindicated to using Menopausal Hormone Therapy?
For: Nick Panay, UK |
|
| 09:45-10:30
09:45-10:00 |
Debate: Estetrol rather than estradiol should be the future of Menopausal Hormone Therapy?
For: Herjan Coelingh Bennink, Netherlands |
|
| 10:30-11:00 | Coffee break, visit the exhibition, and e-poster viewing |
| 11:00-12:30 | POSTMENOPAUSE TREATMENT | HALL C |
| Capsule | ||
| Chairpersons | Nick Panay, UK | |
| 11:00-11:15 | Postmenopausal hormone treatment and the risk for malignancies Johannes Ott, Austria |
|
| 11:15-11:30 | Can AMH predict menopause Frank Broekmans, Netherlands |
|
| 11:30-12:00
11:30-11:40 |
Debate: Should androgens be routinely added to menopause treatment
Yes: Alessandra Graziottin, Italy |
|
| 12:00-12:30
12:00-12:10 |
Debate: Estrogen v non hormonal Rx of osteoporosis > 60 years
For: Cláudio Rebelo, Portugal |
|
| 12:30-13:30 | Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions |
| 13:30-15:00 | SLS – SOCIETY OF LAPAROSCOPIC & ROBOTIC SURGEONS | HALL C |
| Capsule | ||
| Chairpersons | ||
| 15:00-16:30 | UPDATED ESHRE POI GUIDELINE: (ESHRE/MONASH/ASRM/IMS PARTNERSHIP) | HALL C |
| Chairpersons | Nick Panay, UK Bart Fauser, Netherlands |
|
|
15:00-15:20 |
Psychosocial/psychosexual/testosterone issues in POI |
|
|
15:20-15:45 |
Etiology and Genetics of POI |
|
|
15:45-16:05 |
Cardiovascular aspects of POI |
|
|
16:05-16:30 |
Summary of Updated POI Guideline: Key Recommendations |
|
